NCT06443944 2026-04-14
An Expanded Access Program of Cretostimogene Grenadenorepvec for Treatment of NMIBC for Patients Unresponsive to BCG
CG Oncology, Inc.
Available
CG Oncology, Inc.
Janssen Research & Development, LLC
ImmunityBio, Inc.
Aveni Foundation
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
xCures
NanOlogy, LLC